Although there is a favorable trend, thrombopoietic agents did not significantly decrease dose delays and/or reductions compared with placebo or no treatment (21.1% [95% CI: 10.8%, 37.0%] vs 40.4% [95% CI: 9.6%, 81.2%], P = 0.364) ( Fig 2 , Table 2 ).
← all excerpts
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.
1
—
—